JOEL LIPPE: Open Payments
NPI 1780882332 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,133 in 66 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $221 · 2025 $1,133
Food & beverage: $1,133
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $194 |
| GlaxoSmithKline, LLC. | 11 | $161 |
| PFIZER INC. | 6 | $101 |
| Amgen Inc. | 5 | $81 |
| ABBVIE INC. | 4 | $68 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $65 |
| Abbott Laboratories | 3 | $52 |
| Astellas Pharma US Inc | 3 | $51 |
| Aimmune Therapeutics, Inc. | 3 | $47 |
| Exact Sciences Corporation | 3 | $45 |
Products named: AIRSUPRA, SHINGRIX, NURTEC ODT, TRELEGY ELLIPTA, Kerendia, FREESTYLE LIBRE 3, Veozah, OTEZLA.
Industry payments across AZ — which companies pay providers there.
